Evidence map›Paper›PMID 32759053›Full record

ArticleRespiratory medicine and research2020

A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir.

H Joumaa, L Regard, N Carlier, G Chassagnon, E Alabadan, E Canouï, A L'honneur, F Rozenberg, P-R Burgel, N Roche

Abstract readLetterComment
In one paragraph

Article in Respiratory medicine and research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

H JoumaaService de pneumologie, hôpital Cochin, AP-HP, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France.
L RegardService de pneumologie, hôpital Cochin, AP-HP, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France; Université de Paris, institut Cochin, Inserm U1016, 24, rue du Faubourg-Saint-Jacques, 75014 Paris, France.
N CarlierService de pneumologie, hôpital Cochin, AP-HP, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France.
G ChassagnonUniversité de Paris, institut Cochin, Inserm U1016, 24, rue du Faubourg-Saint-Jacques, 75014 Paris, France; Service de Radiologie, hôpital Cochin, AP-HP, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France.
E AlabadanService de pneumologie, hôpital Cochin, AP-HP, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France.
E CanouïÉquipe mobile d'infectiologie, centre université de Paris, site Cochin, AP-HP, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France.
A L'honneurService de virologie, hôpital Cochin, AP-HP, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France.
F RozenbergService de virologie, hôpital Cochin, AP-HP, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France.
P-R BurgelService de pneumologie, hôpital Cochin, AP-HP, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France; Université de Paris, institut Cochin, Inserm U1016, 24, rue du Faubourg-Saint-Jacques, 75014 Paris, France.
N RocheService de pneumologie, hôpital Cochin, AP-HP, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France; Université de Paris, institut Cochin, Inserm U1016, 24, rue du Faubourg-Saint-Jacques, 75014 Paris, France. Electronic address: nicolas.roche@aphp.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19 Drug TreatmentRitonavirHumansLopinavirPandemicsPatientsSARS-CoV-2Virus SheddingLopinavirRitonavirCOVID-19Human immunodeficiency virusLopinavirPneumoniaPulmonary embolism

Identifiers

PMID32759053
PMCPMC7362790

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.